
Oral osteoporosis drug may protect bone density after injection therapy ends, Yuyu says
A new study suggests that Korean drugmaker Yuyu Pharma’s long-selling osteoporosis drug Maxmarvil may help prevent bone loss in postmenopausal women after stopping denosumab, best known under Amgen’s brand Prolia, among others. The real-world study was …